Compounds > fludarabine

fludarabine and Cockayne-Touraine Disease

fludarabine has been researched along with Cockayne-Touraine Disease in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Mathews, W; Muldoon, D; Tolar, J; Vanden Oever, M1
Baxter-Lowe, L; Bruckner, A; Cairo, MS; Chen, M; Christiano, AM; Fabricatore, S; Geyer, MB; Giller, R; Harel, S; Kandel, J; Kiuru, M; LeBoeuf, N; McGrath, J; Morel, KD; Radhakrishnan, K; Uitto, J; Umegaki, N; Woodley, D1

Other Studies

3 other study(ies) available for fludarabine and Cockayne-Touraine Disease

ArticleYear
Fludarabine modulates expression of type VII collagen during haematopoietic stem cell transplantation for recessive dystrophic epidermolysis bullosa.
    The British journal of dermatology, 2021, Volume: 185, Issue:2

    Topics: Collagen Type VII; Epidermolysis Bullosa Dystrophica; Hematopoietic Stem Cell Transplantation; Humans; Phosphatidylinositol 3-Kinases; Vidarabine

2021
Does fludarabine have a beneficial effect in recessive dystrophic epidermolysis bullosa?
    The British journal of dermatology, 2021, Volume: 185, Issue:2

    Topics: Collagen Type VII; Epidermolysis Bullosa Dystrophica; Humans; Skin; Vidarabine

2021
Reduced Toxicity Conditioning and Allogeneic Hematopoietic Progenitor Cell Transplantation for Recessive Dystrophic Epidermolysis Bullosa.
    The Journal of pediatrics, 2015, Volume: 167, Issue:3

    Topics: Alemtuzumab; Antibodies, Monoclonal, Humanized; Busulfan; Child; Collagen Type VII; Epidermolysis Bullosa Dystrophica; Epithelial Cells; Fibroblasts; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Male; Mutation; Myeloablative Agonists; RNA, Messenger; Transplantation Conditioning; Transplantation, Homologous; Vidarabine

2015